Company logo

Scinopharm Taiwan | Sustainability Performance

https://www.scinopharm.com/

Provides active pharmaceutical ingredients and contract development and manufacturing services, focusing on oncology, central nervous system, and other specialized therapeutic fields.

1997

Taiwan

1,001 - 5,000 employees

Pharmaceuticals

$100M - 500M in revenue

$1M - 10M in profitability

Sustainability Ranking & Industry Benchmark

#2625
Overall
#42
in Taiwan
#64
in Pharmaceuticals

Sustainability Maturity


Sustainability Intent

Available in
Scale package

Access

Industry Rank

91 out of 287

Market cap Total market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
15.9B$, 202612.7% YoY
Revenue Total revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
3.4B$, 20246.5% YoY
R&D intensity Research and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.
13.48%2024

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees

We follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

    Available in
    Scale package

    Access